US Enhanced Surveillance Network to Assess Burden, Natural History, and Effectiveness of Vaccines to Prevent Enteric and Respiratory Viruses in Children

The summary for the US Enhanced Surveillance Network to Assess Burden, Natural History, and Effectiveness of Vaccines to Prevent Enteric and Respiratory Viruses in Children grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the Centers for Disease Control and Prevention ERA, which is the U.S. government agency offering this grant.

US Enhanced Surveillance Network to Assess Burden, Natural History, and Effectiveness of Vaccines to Prevent Enteric and Respiratory Viruses in Children: The goal of this Notice of Funding Opportunity (NOFO) is to support a network of US institutions to develop and implement standard research protocols to conduct prospective active surveillance for: a) acute gastroenteritis (AGE) due to norovirus, rotavirus and other enteric viruses; b) acute respiratory illnesses (ARI) due to respiratory viruses including, but not limited to, influenza, RSV, parainfluenza viruses, human metapneumovirus, rhinoviruses, enteroviruses (including EV-D68), adenoviruses, and coronaviruses (including SARS-CoV-2); and c) acute flaccid myelitis (AFM) syndrome and multisystem inflammatory syndrome in children (MIS-C) among pediatric patients seeking healthcare at medical institutions. The network should also provide accurate estimates of the effectiveness in this population of influenza, rotavirus, COVID-19 and other vaccines against respiratory or enteric virus-associated illnesses projected to become available during the period of performance (e.g., RSV, norovirus). Participating institutions should identify AGE, ARI, AFM and MIS-C illnesses among pediatric patients seeking healthcare or diagnostic testing for acute illness in inpatient, outpatient and emergency departments. Recipients should enroll patients meeting standard symptom criteria, and confirm viral infection using approved molecular assays. Vaccine effectiveness (VE) estimates will be calculated. Estimates of VE, burden of disease, and information on the natural history of disease will be used to: a) inform best practices for diagnosis and treatment protocols; b) inform vaccine recommendations; and c) assess public health impact of vaccination and public health programs to prevent viral illness-related healthcare encounters and medical visits among pediatric populations.

Federal Grant Title:	US Enhanced Surveillance Network to Assess Burden, Natural History, and Effectiveness of Vaccines to Prevent Enteric and Respiratory Viruses in Children
Federal Agency Name:	Centers for Disease Control and Prevention ERA (HHS-CDC-HHSCDCERA)
Grant Categories:	Health
Type of Opportunity:	Discretionary
Funding Opportunity Number:	RFA-IP-21-002
Type of Funding:	Cooperative Agreement
CFDA Numbers:	93.185
CFDA Descriptions:	Information not provided
Current Application Deadline:	March 8th, 2021
Original Application Deadline:	March 8th, 2021
Posted Date:	November 17th, 2020
Creation Date:	November 17th, 2020
Archive Date:	March 10th, 2021
Total Program Funding:	$68,250,000
Maximum Federal Grant Award:	$1,950,000
Minimum Federal Grant Award:	$1,600,000
Expected Number of Awards:	7
Cost Sharing or Matching:	No
Last Updated:	March 3rd, 2021

Applicants Eligible for this Grant: State governments - County governments - City or township governments - Special district governments - Independent school districts - Public and State controlled institutions of higher education - Native American tribal governments (Federally recognized) - Public housing authorities/Indian housing authorities - Native American tribal organizations (other than Federally recognized tribal governments) - Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education - Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education - Others (see text field entitled "Additional Information on Eligibility" for clarification.)
Additional Information on Eligibility: Public and private non-profit institutions of higher educationThe following types of Higher Education Institutions are always encouraged to apply for CDC support as Public or Private Nonprofit Institutions of Higher Education:Hispanic-serving InstitutionsHistorically Black Colleges and Universities (HBCUs)Tribally Controlled Colleges and Universities (TCCUs)Alaska Native and Native Hawaiian Serving Institutions
Grant Announcement Contact: Deborah Loveys
[email protected]
Grants Policy
Similar Government Grants: • Partnerships to Enhance Immunization Information Systems (IIS); • Advancing the capacity of immunization program managers through a national coordinating or...; • Understanding Adult Immunization Quality Improvement Approaches Among Adult HCP and Health...; • Developing a Public Health Tool to Predict the Virality of Vaccine Misinformation Narrativ...; • Collaborative Surveys to Provide Inputs into Vaccine-Related Economic Evaluations; • Coordination of Activities Between the CDC's National Immunization Program and the State a...; • National Minority Organizations Immunization Projects; • Using Provider Partnerships to Strengthen the Immunization Message
More Grants from the Centers for Disease Control and Prevention ERA: • Exploratory/Developmental Research for World Trade Center Health Program Evidence-based St...; • Collaborative research on influenza and other respiratory pathogens in South Africa; • Advancing Public Health Research in Bangladesh; • Demonstration Projects to Research and Evaluate Strategies Aligned with CDC's What Works i...; • Public Health Epidemiology, Prevention and Control of Influenza and Other Respiratory Path...